Exane Derivatives’s Hologic HOLX Stock Holding History

Exane Derivatives’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$69	Sell	1 -354	-100%	-$26.3K	﹤0.01%	732
2022 Q1	$27.3K	Sell	355 -12	-3%	-$863	0.01%	632
2021 Q4	$28.1K	Sell	367 -91	-20%	-$6.69K	0.01%	554
2021 Q3	$33.8K	Sell	458 -456	-50%	-$34.2K	0.01%	656
2021 Q2	$62.7K	Sell	914 -941	-51%	-$62.9K	0.01%	615
2021 Q1	$138K	Sell	1,855 -7,444	-80%	-$565K	0.04%	352
2020 Q4	$677K	Buy	9,299 +1,447	+18%	+$102K	0.2%	111
2020 Q3	$522K	Buy	7,852 +416	+6%	+$26.3K	0.15%	125
2020 Q2	$424K	Buy	+7,436	New	+$365K	0.11%	158

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Exane Derivatives's HOLX Position: Q2 2022 in Review

Exane Derivatives reduced its Hologic (HOLX) stake by 100% in Q2 2022, selling an estimated $26.3K and leaving 1 share worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Exane Derivatives first reported a position in HOLX in Q2 2020 and has held it in 9 quarters since. The position peaked at $677K in Q4 2020. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

Exane Derivatives held 1 share of Hologic worth $69 as of Q2 2022.
Exane Derivatives sold 354 Hologic shares in Q2 2022, an estimated $26.3K.
Hologic made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #732 holding.
Exane Derivatives first reported a position in Hologic in Q2 2020 and has held it in 9 quarters since.
Exane Derivatives's Hologic position peaked at $677K in Q4 2020.
695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.